Genetic disorders of the pituitary

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 1, 2012, Pages 33-39

  Cohen, Laurie E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

combined pituitary hormone deficiency; fibroblast growth factor8; GLI2; HESX1; LHX3; LHX4; PITX2; Prophet of Pit 1; SOX3

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR SOX3; UNCLASSIFIED DRUG;

DIENCEPHALON; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS DISEASE; HYPOPHYSIS FUNCTION; MOLECULAR INTERACTION; PHENOTYPE; PITUITARY HORMONE DEFICIENCY; PROTEIN EXPRESSION; REVIEW;

FIBROBLAST GROWTH FACTOR 8; HOMEODOMAIN PROTEINS; HUMANS; HYPOPITUITARISM; LIM-HOMEODOMAIN PROTEINS; MUTATION; OTX TRANSCRIPTION FACTORS; PITUITARY HORMONES; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS;

EID: 84655169672     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32834ed639     Document Type: Review

References (67)

1. Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002; 23:431-442. (Pubitemid 34925640)
2. Kelberman D, Rizzoti K, Lovell-Badge R, et al. Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 2009; 30:790-829.
3. Romero CJ, Pine-Twaddell E, Radovick S. Novel mutations associated with combined pituitary hormone deficiency. J MolEndocrinol2011; 46:R93-R102.
4. Hermesz E, Mackem S, Mahon KA. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 1996; 122:41-52. (Pubitemid 26038417)
5. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/HESX1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19:125-133. (Pubitemid 28248792)
6. Brickman JM, Clements M, Tyrell R, et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001; 128:5189-5199. (Pubitemid 34083044)
7. Mehta A, Dattani MT. Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism. Best Pract Res Clin Endocrinol Metab 2008; 22:191-206. (Pubitemid 351218273)
8. McNay DE, Turton JP, Kelberman D, et al. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab 2007; 92:691-697.
9. Reynaud R, Albarel F, Saveanu A, et al. Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur J Endocrinol 2011; 164:457-465.
10. Dateki S, Kosaka K, Hasegawa K, et al. Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. J Clin Endocrinol Metab 2010; 95:756-764.
11. Tajima T, Ohtake A, Hoshino M, et al. OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab 2009; 94:314-319.
12. Dateki S, Fukami M, Sato N, et al. OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. J Clin Endocrinol Metab 2008; 93:3697-3702.
13. Diaczok D, Romero C, Zunich J, et al. A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. J Clin Endocrinol Metab 2008; 93:4351-4359. (Pubitemid 352789531)
14. Ashkenazi-Hoffnung L, Lebenthal Y, Wyatt AW, et al. A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency. Human genetics 2010; 127:721-729.
15. Gage PJ, Camper SA. Pituitary homeobox 2, a novel member of the bicoidrelated family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet 1997; 6:457-464. (Pubitemid 27116467)
16. Lamonerie T, Tremblay JJ, Lanctot C, et al. Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 1996; 10:1284-1295. (Pubitemid 26171108)
17. Lanctot C, Gauthier Y, Drouin J. Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 1999; 140:1416-1422. (Pubitemid 29104248)
18. Charles MA, Suh H, Hjalt TA, et al. PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol 2005; 19:1893-1903. (Pubitemid 41007900)
19. Semina EV, Reiter RS, Murray JC. Isolation of a new homeobox gene belonging to the Pitx/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19. Hum Mol Genet 1997; 6:2109-2116. (Pubitemid 27477953)
20. Amendt BA, Sutherland LB, Semina EV, Russo AF. The molecular basis of Rieger syndrome: analysis of PITX2 homeodomain protein activities. J Biol Chem 1998; 273:20066-20072. (Pubitemid 28377559)
21. Zhadanov AB, Bertuzzi S, Taira M, et al. Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dyn 1995; 202:354-364.
22. Bach I, Rhodes SJ, Pearse RV II, et al. P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with PIT-1. Proc Natl Acad Sci U S A 1995; 92:2720-2724.
23. Sobrier ML, Attie-Bitach T, Netchine I, et al. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expr Patterns 2004; 5:279-284. (Pubitemid 39618939)
24. Sloop KW, Meier BC, Bridwell JL, et al. Differential activation of pituitary hormone genes by human Lhx3 isoforms with distinct DNA binding properties. Mol Endocrinol 1999; 13:2212-2225. (Pubitemid 30637279)
25. Pfaeffle RW, Savage JJ, Hunter CS, et al. Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. J Clin Endocrinol Metab 2007; 92:1909-1919. (Pubitemid 46997209)
26. Rajab A, Kelberman D, de Castro SC, et al. Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet 2008; 17:2150-2159. (Pubitemid 351911984)
27. Kristrom B, Zdunek AM, Rydh A, et al. A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations. J Clin Endocrinol Metab 2009; 94:1154-1161.
28. Bonfig W, Krude H, Schmidt H. A novel mutation of LHX3 is associated with combined pituitary hormone deficiency including ACTH deficiency, sensorineural hearing loss, and short neck-a case report and review of the literature. Eur J Pediatr 2011; 170:1017-1021.
29. Li H, Witte DP, Branford WW, et al. Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survival. Embo J 1994; 13:2876-2885. (Pubitemid 24191698)
30. Watkins-Chow DE, Camper SA. How many homeobox genes does it take to make a pituitary gland? Trends Genet 1998; 14:284-290.
31. Sheng HZ, Moriyama K, Yamashita T, et al. Multistep control of pituitary organogenesis. Science 1997; 278:1809-1812. (Pubitemid 27527650)
32. Machinis K, Pantel J, Netchine I, et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001; 69:961-968. (Pubitemid 33015811)
33. Dateki S, Fukami M, Uematsu A, et al. Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. J Clin Endocrinol Metab 2010; 95:4043-4047.
34. Tajima T, Yorifuji T, Ishizu K, Fujieda K. A novel mutation (V101A) of the LHX4 gene in a Japanese patient with combined pituitary hormone deficiency. Exp Clin Endocrinol Diabetes 2010; 118:405-409.
35. Rizzoti K, Brunelli S, Carmignac D, et al. SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 2004; 36:247-255. (Pubitemid 38282749)
36. Solomon NM, Nouri S, Warne GL, et al. Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics 2002; 79:553-559. (Pubitemid 34274297)
37. Alatzoglou KS, Kelberman D, Cowell CT, et al. Increased transactivation associated with SOX3 polyalanine tract deletion in a patient with hypopituitarism. J Clin Endocrinol Metab 2011; 96:E685-E690.
38. Laumonnier F, Ronce N, Hamel BC, et al. Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 2002; 71:1450-1455. (Pubitemid 36015898)
39. Woods KS, Cundall M, Turton J, et al. Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 2005; 76:833-849. (Pubitemid 40563104)
40. McCabe MJ, Gaston-Massuet C, Tziaferi V, et al. Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo- pituitary dysfunction. J Clin Endocrinol Metab 2011; 96:E1709-E1718.
41. Wang Y, Martin JF, Bai CB. Direct and indirect requirements of Shh/Gli signaling in early pituitary development. Dev Biol 2010; 348:199-209.
42. Franca MM, Jorge AA, Carvalho LR, et al. Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly. J Clin Endocrinol Metab 2010; 95:E384-E391.
43. Dutour A. A new step understood in the cascade of tissue-specific regulators orchestrating pituitary lineage determination: the Prophet of Pit-1 (Prop-1). Eur J Endocrinol 1997; 137:616-617. (Pubitemid 28005253)
44. Dasen JS, Barbera JP, Herman TS, et al. Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 2001; 15:3193-3207. (Pubitemid 33115682)
45. Fluck C, Deladoey J, Rutishauser K, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg->Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998; 83:3727-3734. (Pubitemid 28500916)
46. Lebl J, Vosahlo J, Pfaeffle RW, et al. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Eur J Endocrinol 2005; 153:389-396. (Pubitemid 41410495)
47. Vieira TC, da Silva MR, Abucham J. The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency. Endocrine 2006; 30:365-369. (Pubitemid 47010973)
48. Deladoey J, Fluck C, Buyukgebiz A, et al. Hot spot'' in the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1999; 84:1645-1650. (Pubitemid 30644269)
49. Bottner A, Keller E, Kratzsch J, et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab 2004; 89:5256-5265. (Pubitemid 39391475)
50. Pavel ME, Hensen J, Pfaffle R, et al. Long-term follow-up of childhood-onsethypopituitarism in patients with the PROP-1 gene mutation. Horm Res 2003; 60:168-173. (Pubitemid 37256062)
51. Romero CJ, Nesi-Franca S, Radovick S. The molecular basis of hypopituitarism. Trends Endocrinol Metab 2009; 20:506-516.
52. Zhang H, Wang Y, Han L, et al. A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees. Horm Res Paediatr 2010; 74:98-105.
53. Nystrom HF, Saveanu A, Barbosa EJ, et al. Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency. Pituitary 2011; 14:208-216.
54. Bodner M, Castrillo JL, Theill LE, et al. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 1988; 55:505-518.
55. Simmons DM, Voss JW, Ingraham HA, et al. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 1990; 4:695-711.
56. Tatsumi K, Miyai K, Notomi T, et al. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992; 1:56-58.
57. Radovick S, Nations M, Du Y, et al. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992; 257:1115-1118.
58. Pfaffle RW, DiMattia GE, Parks JS, et al. Mutation of the POU-specific domain of PIT-1 and hypopituitarism without pituitary hypoplasia. Science 1992; 257:1118-1121.
59. Ohta K, Nobukuni Y, Mitsubuchi H, et al. Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992; 189:851-855. (Pubitemid 23032452)
60. Inoue H, Mukai T, Sakamoto Y, et al. Identification of a novel mutation in the exon 2 splice donor site of the POU1F1/PIT-1 gene in Japanese identical twins with mild combined pituitary hormone deficiency. Clin Endocrinol (Oxf) 2011; doi: 10.1111/j.1365-2265.2011.04165.x.
61. Cohen LE, Wondisford FE, Salvatoni A, et al. A 'hot spot' in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 1995; 80:679-684.
62. Turton JP, Reynaud R, Mehta A, et al. Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 2005; 90:4762-4770. (Pubitemid 41159369)
63. Jacobson EM, Li P, Leon-del-Rio A, et al. Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev 1997; 11:198-212. (Pubitemid 27081896)
64. Cohen LE, Zanger K, Brue T, et al. Defective retinoic acid regulation of the PIT- 1 gene enhancer: a novel mechanism of combined pituitary hormone deficiency. Mol Endocrinol 1999; 13:476-484. (Pubitemid 29113879)
65. Tenenbaum-Rakover Y, Sobrier ML, Amselem S. A novel POU1F1 mutation (p.Thr168IlefsX7) associated with an early and severe form of combined pituitary hormone deficiency: functional analysis and follow-up from infancy to adulthood. Clin Endocrinol (Oxf) 2011; 75:214-219.
66. De Graaff LC, Argente J, Veenma DC, et al. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3'1/'2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. Horm Res Paediatr 2010; 73:363-371.
67. Pfaffle R, Klammt J. Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab 2011; 25:43-60.